Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Vir Biotechnology Inc., 3 years.
Vir Biotechnology Inc.
Director
Mirum Pharmaceuticals Inc.
Director
Faeth Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | Mirum Pharmaceuticals Inc. | Open-market sale | −3,977 | $100.00 | $397,700 |
| May 29, 2026 | Mirum Pharmaceuticals Inc. | Option exercise | +3,977 | — | — |
| May 15, 2026 | Mirum Pharmaceuticals Inc. | Option exercise | +2,000 | $23.51 | $47,020 |
| May 15, 2026 | Mirum Pharmaceuticals Inc. | Open-market sale | −2,000 | $109.47 | $218,940 |
| Apr 15, 2026 | Mirum Pharmaceuticals Inc. | Option exercise | +2,000 | $23.51 | $47,020 |
| Apr 15, 2026 | Mirum Pharmaceuticals Inc. | Open-market sale | −2,000 | $96.90 | $193,800 |
| Mar 16, 2026 | Mirum Pharmaceuticals Inc. | Option exercise | +2,000 | $23.51 | $47,020 |
| Mar 16, 2026 | Mirum Pharmaceuticals Inc. | Open-market sale | −2,000 | $90.76 | $181,520 |
| Feb 13, 2026 | Mirum Pharmaceuticals Inc. | Option exercise | +2,000 | $23.51 | $47,020 |
| Feb 13, 2026 | Mirum Pharmaceuticals Inc. | Open-market sale | −2,000 | $102.09 | $204,180 |
| Jan 15, 2026 | Mirum Pharmaceuticals Inc. | Option exercise | +2,000 | $23.51 | $47,020 |
| Jan 15, 2026 | Mirum Pharmaceuticals Inc. | Open-market sale | −2,000 | $90.99 | $181,980 |
| Dec 22, 2025 | Mirum Pharmaceuticals Inc. | Option exercise | +5,000 | $23.51 | $117,550 |
| Dec 22, 2025 | Mirum Pharmaceuticals Inc. | Open-market sale | −5,000 | $80.00 | $400,000 |
| Dec 18, 2025 | Mirum Pharmaceuticals Inc. | Option exercise | +2,000 | $23.51 | $47,020 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.